Evidence-Based Practice Education for Dizziness
(DIZZTINCT2 Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial focuses on improving dizziness treatment in emergency rooms, particularly for conditions like vertigo, vestibular neuritis (inflammation of the inner ear nerve), and strokes. Researchers aim to evaluate how educational materials and strategies assist doctors and patients in managing these conditions more effectively. Participants may receive either special educational resources or standard care, depending on their group. Individuals who have been discharged from an ER visit for dizziness in the past 48 hours and speak English or Spanish may be suitable candidates. As an unphased trial, this study provides a unique opportunity to enhance emergency care for dizziness.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
Do I need to stop my current medications for this trial?
The trial protocol does not specify whether you need to stop taking your current medications.
What prior data suggests that this educational intervention is safe for dizziness management?
Previous studies have shown that educational programs for dizziness are safe for people. Research on Continuing Medical Education (CME) activities, like those in this trial, generally shows they are well-tolerated. No harmful effects have been reported from these programs.
Additionally, studies indicate that educational materials for patients, such as those used in exercises for balance and dizziness, are safe and effective. These materials have been safely used to help people understand and manage conditions like benign paroxysmal positional vertigo (BPPV).
Both the CME educational programs for healthcare providers and the educational materials for patients have a strong safety record. They aim to improve understanding and treatment without causing harm.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it explores a new approach to managing dizziness through targeted education for both healthcare providers and patients. Unlike traditional treatments for dizziness that often focus solely on medications or vestibular rehabilitation exercises, this trial emphasizes the power of education to improve patient outcomes. By equipping physicians with the DIZZTINCT educational intervention and providing patients with tailored educational materials, the trial aims to enhance understanding, diagnosis, and management of dizziness. This could potentially lead to more informed decision-making and better tailored treatments, making it a promising area of research for improving care in dizziness management.
What evidence suggests that this trial's educational interventions could be effective for dizziness management?
This trial will evaluate the impact of educational interventions on dizziness management. Research has shown that teaching both doctors and patients can help manage dizziness, such as the common inner ear issue BPPV. In this trial, some groups will have physicians receiving a Continuing Medical Education (CME) intervention, while others will not. One study found that when doctors learned more about BPPV, they provided better care, leading to improved patient outcomes. Additionally, some groups will involve patients receiving educational materials developed for dizziness management. Another study showed that when patients used educational materials to learn how to manage BPPV themselves, they felt more confident and experienced less dizziness over time. Furthermore, studies indicate that resources like booklets can help patients stick to exercises, improve their balance, and reduce dizziness. These findings suggest that educating both doctors and patients effectively manages dizziness.23567
Who Is on the Research Team?
Kevin Kerber, MD
Principal Investigator
Ohio State University
Huong Nguyen, PhD
Principal Investigator
Kaiser Permanente
Will Meurer, MD
Principal Investigator
University of Michigan
Are You a Good Fit for This Trial?
This trial is for adults over 18 who've been discharged from certain emergency departments in the last 48 hours with a primary diagnosis of dizziness or related vestibular disorders. Participants must be Kaiser Permanente members, speak English or Spanish, and able to consent. Those with severe trauma, previous study enrollment, or inability to consent are excluded.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Pre-Intervention
Initial no intervention period to establish baseline data
Intervention
Randomized staggered intervention at EDs with CME sessions and patient education materials
Follow-up
Participants are monitored for documentation of DHT/CRM and dizziness disability using DHI
What Are the Treatments Tested in This Trial?
Interventions
- CME Educational Intervention
- Study Developed Educational Materials for Patients
Find a Clinic Near You
Who Is Running the Clinical Trial?
Ohio State University
Lead Sponsor
National Institute on Deafness and Other Communication Disorders (NIDCD)
Collaborator
Kaiser Permanente
Collaborator
University of Michigan
Collaborator